Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00942604 · ClinicalTrials.gov registry record · Phase 3
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
A Phase 3 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 3
- Development phase
- 203
- Enrollment target
NCT00942604 is a Phase 3 study that has completed, run by Peplin. The registered enrollment target is 203 participants.
The verdict
NCT00942604, a Phase 3 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 203 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.
Interventions
- DRUG Vehicle gel
- DRUG PEP005 (ingenol mebutate) Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00942604
The ClinicalTrials.gov registry entry for NCT00942604 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peplin, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle gel is the first listed.
NCT00942604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00942604 about?
NCT00942604 is a clinical study titled "A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations". The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.
What is the current status of trial NCT00942604?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 203 participants. The study started on 2009-07. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00942604?
The interventions under investigation include: Vehicle gel (DRUG), PEP005 (ingenol mebutate) Gel (DRUG).
Who is sponsoring clinical trial NCT00942604?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.